314 related articles for article (PubMed ID: 15659599)
1. Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta.
Racke MM; Boone LI; Hepburn DL; Parsadainian M; Bryan MT; Ness DK; Piroozi KS; Jordan WH; Brown DD; Hoffman WP; Holtzman DM; Bales KR; Gitter BD; May PC; Paul SM; DeMattos RB
J Neurosci; 2005 Jan; 25(3):629-36. PubMed ID: 15659599
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy reduces vascular amyloid-beta in PDAPP mice.
Schroeter S; Khan K; Barbour R; Doan M; Chen M; Guido T; Gill D; Basi G; Schenk D; Seubert P; Games D
J Neurosci; 2008 Jul; 28(27):6787-93. PubMed ID: 18596154
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice.
Fryer JD; Taylor JW; DeMattos RB; Bales KR; Paul SM; Parsadanian M; Holtzman DM
J Neurosci; 2003 Aug; 23(21):7889-96. PubMed ID: 12944519
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging detection and time course of cerebral microhemorrhages during passive immunotherapy in living amyloid precursor protein transgenic mice.
Luo F; Rustay NR; Seifert T; Roesner B; Hradil V; Hillen H; Ebert U; Severin JM; Cox BF; Llano DA; Day M; Fox GB
J Pharmacol Exp Ther; 2010 Dec; 335(3):580-8. PubMed ID: 20823195
[TBL] [Abstract][Full Text] [Related]
5. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
[TBL] [Abstract][Full Text] [Related]
6. Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging.
Prada CM; Garcia-Alloza M; Betensky RA; Zhang-Nunes SX; Greenberg SM; Bacskai BJ; Frosch MP
J Neurosci; 2007 Feb; 27(8):1973-80. PubMed ID: 17314293
[TBL] [Abstract][Full Text] [Related]
7. Anti-Aβ Antibodies and Cerebral Amyloid Angiopathy Complications.
Chantran Y; Capron J; Alamowitch S; Aucouturier P
Front Immunol; 2019; 10():1534. PubMed ID: 31333665
[TBL] [Abstract][Full Text] [Related]
8. Low avidity and level of serum anti-Aβ antibodies in patients with cerebral amyloid angiopathy-related cerebral hemorrhage.
Cao Z; Lv J; Quan W
Int J Neurosci; 2010 Dec; 120(12):760-4. PubMed ID: 20954837
[TBL] [Abstract][Full Text] [Related]
9. Vascular alterations in PDAPP mice after anti-Aβ immunotherapy: Implications for amyloid-related imaging abnormalities.
Zago W; Schroeter S; Guido T; Khan K; Seubert P; Yednock T; Schenk D; Gregg KM; Games D; Bard F; Kinney GG
Alzheimers Dement; 2013 Oct; 9(5 Suppl):S105-15. PubMed ID: 23583235
[TBL] [Abstract][Full Text] [Related]
10. Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivity.
Bales KR; O'Neill SM; Pozdnyakov N; Pan F; Caouette D; Pi Y; Wood KM; Volfson D; Cirrito JR; Han BH; Johnson AW; Zipfel GJ; Samad TA
Brain; 2016 Feb; 139(Pt 2):563-77. PubMed ID: 26493635
[TBL] [Abstract][Full Text] [Related]
11. Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice.
Bard F; Fox M; Friedrich S; Seubert P; Schenk D; Kinney GG; Yednock T
Exp Neurol; 2012 Nov; 238(1):38-43. PubMed ID: 22892246
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-beta vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid.
Wilcock DM; Jantzen PT; Li Q; Morgan D; Gordon MN
Neuroscience; 2007 Feb; 144(3):950-60. PubMed ID: 17137722
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier integrity in a mouse model of Alzheimer's disease with or without acute 3D6 immunotherapy.
Gustafsson S; Gustavsson T; Roshanbin S; Hultqvist G; Hammarlund-Udenaes M; Sehlin D; Syvänen S
Neuropharmacology; 2018 Dec; 143():1-9. PubMed ID: 30201212
[TBL] [Abstract][Full Text] [Related]
14. CD40L disruption enhances Abeta vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation.
Obregon D; Hou H; Bai Y; Nikolic WV; Mori T; Luo D; Zeng J; Ehrhart J; Fernandez F; Morgan D; Giunta B; Town T; Tan J
Neurobiol Dis; 2008 Feb; 29(2):336-53. PubMed ID: 18055209
[TBL] [Abstract][Full Text] [Related]
15. A plaque-specific antibody clears existing β-amyloid plaques in Alzheimer's disease mice.
Demattos RB; Lu J; Tang Y; Racke MM; Delong CA; Tzaferis JA; Hole JT; Forster BM; McDonnell PC; Liu F; Kinley RD; Jordan WH; Hutton ML
Neuron; 2012 Dec; 76(5):908-20. PubMed ID: 23217740
[TBL] [Abstract][Full Text] [Related]
16. Intracerebroventricular passive immunization in transgenic mouse models of Alzheimer's disease.
Chauhan NB; Siegel GJ
Expert Rev Vaccines; 2004 Dec; 3(6):717-25. PubMed ID: 15606357
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic modulation of cerebral microhemorrhage in a mouse model of cerebral amyloid angiopathy.
Fisher M; Vasilevko V; Passos GF; Ventura C; Quiring D; Cribbs DH
Stroke; 2011 Nov; 42(11):3300-3. PubMed ID: 21903962
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice.
Wilcock DM; Colton CA
CNS Neurol Disord Drug Targets; 2009 Mar; 8(1):50-64. PubMed ID: 19275636
[TBL] [Abstract][Full Text] [Related]
19. Intracerebroventricular amyloid-beta antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice.
Thakker DR; Weatherspoon MR; Harrison J; Keene TE; Lane DS; Kaemmerer WF; Stewart GR; Shafer LL
Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4501-6. PubMed ID: 19246392
[TBL] [Abstract][Full Text] [Related]
20. Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice.
Wilcock DM; Alamed J; Gottschall PE; Grimm J; Rosenthal A; Pons J; Ronan V; Symmonds K; Gordon MN; Morgan D
J Neurosci; 2006 May; 26(20):5340-6. PubMed ID: 16707786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
